Detalles de la búsqueda
1.
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Br J Cancer
; 128(1): 30-41, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335217
2.
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Br J Cancer
; 128(2): 400, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36697966
Resultados
1 -
2
de 2
1
Próxima >
>>